Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study

Show full item record



Permalink

http://hdl.handle.net/10138/326390

Citation

Puolanne , A-M , Kolho , K-L , Alfthan , H & Färkkilä , M 2019 , ' Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study ' , Scandinavian Journal of Gastroenterology , vol. 54 , no. 7 , pp. 849-854 . https://doi.org/10.1080/00365521.2019.1618910

Title: Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study
Author: Puolanne, Anna-Maija; Kolho, Kaija-Leena; Alfthan, Henrik; Färkkilä, Martti
Contributor: University of Helsinki, Gastroenterologian yksikkö
University of Helsinki, Children's Hospital
University of Helsinki, HUSLAB
University of Helsinki, Centre of Excellence in Complex Disease Genetics
Date: 2019-07-03
Language: eng
Number of pages: 6
Belongs to series: Scandinavian Journal of Gastroenterology
ISSN: 0036-5521
URI: http://hdl.handle.net/10138/326390
Abstract: Objectives: The aim of this prospective study was to evaluate the home monitoring with a rapid fecal calprotectin test combined with a symptom questionnaire in patients with colonic IBD in real-life setting. Methods: We randomized 180 patients with colonic IBD in a study or a control group. The home monitoring patients performed the fecal calprotectin test and filled in a symptom questionnaire every second month and in cases with increasing symptoms. The control patients filled in the symptom questionnaire at baseline and at 6 and 12 months as well as for the appointment at the outpatient clinic. The study duration was 12 months. Results: The patient adherence to the self-monitoring program was low. Patients with a higher disease burden were more adherent than patients with better health-related quality of life, but otherwise, there were no significant factors predicting the adherence. The home monitoring patients had fewer contacts with the outpatient clinic, but otherwise, the disease course between the home monitoring and the control group were similar. Conclusions: The self-monitoring of IBD activity with a combination of a rapid fecal calprotectin home test and a symptom questionnaire provides an option for individualized care for IBD patients. However, adherence to the self-monitoring program remains a challenge.
Subject: Crohn ' s disease
fecal calprotectin
disease activity
ulcerative colitis
QUALITY-OF-LIFE
FECAL CALPROTECTIN
ULCERATIVE-COLITIS
E-HEALTH
TELEMEDICINE
MANAGEMENT
RELAPSE
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Final_Home_monitoring_of_IBD_.pdf 238.0Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record